Invenomic Capital Management LP
Invenomic Capital Management LP reported 117 positions worth $2.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: UHS (3.9%). Biggest move: new buy AMTM ($66.7M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | UHS | $79.6M | 3.91% | 456,662 | — | — | +13.5% | |
| ▸ 2 | GPN | $68.2M | 3.35% | 835,167 | — | — | +10.0% | |
| ▸ 3 | AMTM | $66.7M | 3.28% | 3,683,718 | — | — | +18.5% | |
| ▸ 4 | ST | $62.1M | 3.05% | 1,493,441 | — | — | -10.3% | |
| ▸ 5 | GDDY | $56.6M | 2.78% | 592,670 | — | — | +17.5% | |
| ▸ 6 | OMC | $55.0M | 2.70% | 747,200 | — | — | +19.5% | |
| ▸ 7 | FIS | $54.2M | 2.66% | 1,648,002 | — | — | -14.0% | |
| ▸ 8 | CHTR | $51.8M | 2.54% | 467,348 | — | — | +25.3% | |
| ▸ 9 | PVH | $50.1M | 2.46% | 676,078 | — | — | +26.0% | |
| ▸ 10 | SPSC | $49.7M | 2.44% | 602,292 | — | — | -0.9% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Invenomic Capital Management LP hold as of Q3 2026?
Invenomic Capital Management LP reported 117 positions worth $2.04B in its Q3 2026 13F filing. Largest positions: UHS (3.9%), GPN (3.3%), AMTM (3.3%), ST (3.0%) and GDDY (2.8%).
What did Invenomic Capital Management LP buy in Q3 2026?
New positions: AMTM, GDDY, OCTV, RRX and EFOR (37 in all). Added to: ST, SFM, GEHC, KBR and CHTR (46 in all).
What did Invenomic Capital Management LP sell in Q3 2026?
Reduced: WDAY, CRM, SPSC, FISV and EGO (30 in all). Sold out entirely: BDX, BILL, PATH, FIVN and HAE (36 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.